04/12/2024 6:16 AM | Werewolf Therapeutics (Filer)
| Form DEF 14A | |
04/12/2024 6:17 AM | Werewolf Therapeutics (Filer)
| Form DEFA14A | |
04/12/2024 6:18 AM | Werewolf Therapeutics (Filer)
| Form ARS | |
03/07/2024 6:22 AM | Werewolf Therapeutics (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/07/2024 6:11 AM | Werewolf Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/07/2024 6:15 AM | Werewolf Therapeutics (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/14/2024 4:17 PM | RA CAPITAL MANAGEMENT, L.P. (Filed by) Werewolf Therapeutics (Subject)
| Form SC 13D/A | |
|
02/13/2024 5:58 PM | BANK OF AMERICA CORP /DE/ (Filed by) Werewolf Therapeutics (Subject)
| Form SC 13G | |
02/12/2024 5:06 AM | Rubric Capital Management LP (Filed by) Werewolf Therapeutics (Subject)
| Form SC 13G/A | |
02/09/2024 3:39 PM | Werewolf Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/09/2024 3:35 PM | Werewolf Therapeutics (Filer)
| Form 424B5 | |
01/08/2024 7:08 AM | Werewolf Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/04/2024 6:19 PM | Atkins Michael B. (Reporting) Werewolf Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/04/2024 6:13 PM | Atkins Michael B. (Reporting) Werewolf Therapeutics (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
12/21/2023 3:30 PM | ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by) Werewolf Therapeutics (Subject)
| Form SC 13G | |
11/14/2023 3:34 PM | Werewolf Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/03/2023 6:05 AM | Werewolf Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/18/2023 6:00 AM | Werewolf Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/10/2023 6:00 AM | Werewolf Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/10/2023 6:16 AM | Werewolf Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/27/2023 3:34 PM | Werewolf Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/23/2023 4:07 PM | Morrison Briggs (Reporting) Werewolf Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/23/2023 4:09 PM | Kolchinsky Peter (Reporting) RA Capital Healthcare Fund LP (Reporting) RA CAPITAL MANAGEMENT, L.P. (Reporting) Shah Rajeev M. (Reporting) Werewolf Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/23/2023 3:48 PM | Sherman Michael A. (Reporting) Werewolf Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/23/2023 3:49 PM | Chatterjee Meeta (Reporting) Werewolf Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/23/2023 3:52 PM | DiRocco Derek (Reporting) Werewolf Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/23/2023 3:52 PM | Lazarus Alon (Reporting) Werewolf Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/23/2023 3:53 PM | EVNIN LUKE (Reporting) Werewolf Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/11/2023 6:05 AM | Werewolf Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/11/2023 6:07 AM | Werewolf Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
04/27/2023 7:21 AM | Werewolf Therapeutics (Filer)
| Form DEF 14A | |
04/27/2023 7:24 AM | Werewolf Therapeutics (Filer)
| Form DEFA14A | |